Prophylactic therapy using epigenetic agents for RUNX1::RUNXT1-positive high-risk AML after Allo-HSCT
Annals of Hematology · 2024
DOI: 10.1007/s00277-024-05853-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Wenwen Guo und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clin…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Core Binding Factor Alpha 2 Subunit, Hematopoietic Stem Cell Transplantation, Epigenesis, Genetic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities Funds, National Natural Science Foundation of China, Key Project of Tianjin Natural Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sc…
- Tianjin Institutes of Health Science, Tianjin, 301600, China.
- Tianjin Institutes of Health Science, Tianjin, 301600, China. caoyigeng@ihcams.ac.cn.
Förderung
- Fundamental Research Funds for the Central Universities Funds
- National Natural Science Foundation of China
- Key Project of Tianjin Natural Science Foundation
- Tianjin Health Science and Technology Project
- Haihe Laboratory of Cell Ecosystem Innovation Fund
Zitieren
APA
Guo, W., Zhang, H., Zheng, Y., Gao, H., Zhai, W., Zhang, R., Ma, Q., Yang, D., He, Y., Xia, Y., Pang, A., Feng, S., Han, M., Cao, Y., & Jiang, E. (2024). Prophylactic therapy using epigenetic agents for RUNX1::RUNXT1-positive high-risk AML after Allo-HSCT. Annals of Hematology. https://doi.org/10.1007/s00277-024-05853-2
Vancouver
Guo W, Zhang H, Zheng Y, Gao H, Zhai W, Zhang R, et al. Prophylactic therapy using epigenetic agents for RUNX1::RUNXT1-positive high-risk AML after Allo-HSCT. Annals of Hematology. 2024. doi:10.1007/s00277-024-05853-2
BibTeX
@article{Guo2024,
author = {Guo, Wenwen and Zhang, Haixiao and Zheng, Yawei and Gao, Hongye and Zhai, Weihua and Zhang, Rongli and Ma, Qiaoling and Yang, Donglin and He, Yi and Xia, Yonghui and Pang, Aiming and Feng, Sizhou and Han, Mingzhe and Cao, Yigeng and Jiang, Erlie},
title = {Prophylactic therapy using epigenetic agents for RUNX1::RUNXT1-positive high-risk AML after Allo-HSCT},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-024-05853-2}
}
EUVIMED